Clinical practice guidelines for the prevention and diagnosis of lung cancer

This work consolidates the internationally unique, wiki-based revision of the 2004 first Australian evidence-based “Clinical guidelines for the prevention, diagnosis and management of lung cancer” paperback format with endorsement by the National Health and Medical Research Council.

The work, initially commissioned by Cancer Australia (CA), was undertaken by the CCA to develop a sustainable web-based wiki platform with revised guidelines for the treatment of lung cancer with the first phase being restricted to the treatment of non-small cell and small cell lung cancer (chapters 5 and 6 respectively of the 2004 version) and supporting the patient and palliative care (chapters 4, 7 and 8), now publicly available and widely used at Clinical practice guidelines for the treatment of lung cancer.

The success of the treatment recommendations in guiding clinical practice in Australia has now enabled CCA to move to the second phase, addressing topics of prevention, screening, diagnosis and assessment. To kick off this next phase, we present 3 draft guidelines pertaining to the screening of lung cancer, timely given the increasing interest in low dose CT (LDCT) screening around the world based on the pivotal NLST trial.

*Note: If you experience difficulty accessing this guideline please contact us on [email protected]